Nordic Pharma Plan ApS: Financial statements 2025
CVR: 45535339
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nordic Pharma Plan ApS (CVR 45535339) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,880,281 and a net result of DKK 455,887. Equity in the 2025 report amounted to DKK 597,049. The solvency ratio was 38.9%.
- Gross Profit
- DKK 2,880,281
- Profit/Loss
- DKK 455,887
- Equity
- DKK 597,049
- Total Assets
- DKK 1,536,617
Official annual report
How creditworthy is Nordic Pharma Plan ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of April 23, 2025, Rasmussen Group ApS is registered as an owner of Nordic Pharma Plan ApS with an ownership share of 100%.
As of April 8, 2025, Jimmi Sander Rasmussen is registered as director of Nordic Pharma Plan ApS.
Nordic Pharma Plan ApS was founded on April 8, 2025.
About Nordic Pharma Plan ApS
Nordic Pharma Plan ApS is a Danish company of the type Anpartsselskab based in Frederiksværk, founded in 2025. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Jimmi Sander Rasmussen. The company is owned by Rasmussen Group ApS. In 2025, the company reported a gross profit of DKK 2,880,281 and a net result of DKK 455,887. Equity in the 2025 report amounted to DKK 597,049.